{
  "name": "Schizophrenia",
  "slug": "schizophrenia",
  "type": "condition",
  "metadata": {
    "category": "psychotic-disorders",
    "dsm5_code": "295.90",
    "icd10_code": "F20.9"
  },
  "content": {
    "description": "A chronic mental disorder characterized by persistent disturbances in thought, perception, emotions, and behavior, often including delusions, hallucinations, disorganized speech, and impaired functioning.",
    "diagnostic_criteria": "A. Two or more of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated), and at least one must be (1), (2), or (3): (1) delusions, (2) hallucinations, (3) disorganized speech, (4) grossly disorganized or catatonic behavior, (5) negative symptoms. B. For a significant portion of the time since onset, level of functioning in one or more major areas (work, interpersonal relations, self-care) is markedly below the level achieved prior to onset. C. Continuous signs of disturbance persist for at least 6 months, with at least 1 month of active-phase symptoms. D. Schizoaffective disorder and mood disorder with psychotic features have been ruled out. E. Not attributable to a substance or another medical condition.",
    "prevalence": "Lifetime prevalence is approximately 0.3%â€“0.7% worldwide.",
    "age_of_onset": "Typically late adolescence to early 30s; earlier onset in males (late teens to early 20s) than females (mid-20s to early 30s).",
    "prognosis": "Variable course; about one-third achieve significant recovery, while others have persistent symptoms and functional impairment. Early intervention and consistent treatment improve long-term outcomes.",
    "neurobiology": {
      "circuitry": [
        "Dysfunction in fronto-temporal-limbic circuits affecting cognition, perception, and emotional regulation."
      ],
      "neurochemistry": [
        "Dopamine dysregulation (mesolimbic hyperactivity linked to positive symptoms; mesocortical hypoactivity linked to negative symptoms).",
        "Glutamatergic NMDA receptor hypofunction and GABAergic deficits."
      ],
      "structural_findings": [
        "Enlarged ventricles",
        "Reduced gray matter volume in prefrontal and temporal cortices"
      ],
      "genetic_environmental": "Heritability ~80%; environmental factors include prenatal infections, obstetric complications, early cannabis use, and psychosocial stress."
    },
    "evaluation": {
      "history_psychosocial": [
        "Detailed timeline of psychotic symptoms, prodromal changes, and functional decline.",
        "Family psychiatric history and psychosocial stressors."
      ],
      "medical_assessment": [
        "Rule out substance-induced psychosis and medical causes (thyroid, neurologic, infectious).",
        "Basic labs, urine toxicology, neuroimaging if indicated."
      ],
      "standardized_measures": [
        "PANSS (Positive and Negative Syndrome Scale)",
        "BPRS (Brief Psychiatric Rating Scale)",
        "SANS/SAPS for negative/positive symptoms"
      ],
      "risk_stratification": [
        "Suicide risk is elevated, especially early in illness and after discharge.",
        "Assess aggression risk in acute psychosis."
      ],
      "differential_diagnosis": [
        "Schizoaffective disorder",
        "Bipolar disorder with psychotic features",
        "Major depressive disorder with psychotic features",
        "Delusional disorder",
        "Substance/medication-induced psychotic disorder"
      ],
      "team_and_process": "Multidisciplinary approach with psychiatry, psychology, social work, and occupational therapy."
    },
    "symptoms": {
      "core": [
        "Delusions",
        "Hallucinations",
        "Disorganized speech",
        "Grossly disorganized or catatonic behavior",
        "Negative symptoms (avolition, alogia, anhedonia, flat affect)"
      ],
      "associated": ["Cognitive deficits", "Social withdrawal", "Poor insight"]
    },
    "severity_levels": {
      "mild": "Symptoms present but partially compensated; functioning impaired but some independence maintained.",
      "moderate": "Ongoing symptoms with significant impairment in work, social, and self-care domains.",
      "severe": "Severe psychosis or negative symptoms with profound functional disability."
    },
    "risk_factors": {
      "biological": [
        "Family history of schizophrenia or other psychotic disorders",
        "Genetic variants affecting dopamine/glutamate pathways"
      ],
      "psychological": ["History of trauma or neglect", "Cognitive vulnerabilities"],
      "environmental": [
        "Urban upbringing",
        "Prenatal/perinatal complications",
        "Substance use (especially cannabis)"
      ]
    },
    "impact_on_life": {
      "school_work": "Decline in academic/work performance due to disorganization, cognitive deficits, and social withdrawal.",
      "social": "Relationship strain from odd behavior, paranoia, or withdrawal.",
      "medical": "Side effects from antipsychotic medications (metabolic syndrome, movement disorders).",
      "emotional": "Frustration, hopelessness, or lack of motivation."
    },
    "comorbidities": [
      "Substance use disorders",
      "Anxiety disorders",
      "Depression",
      "Metabolic syndrome",
      "Cardiovascular disease"
    ],
    "treatment_approaches": {
      "psychotherapy": ["CBT for psychosis", "Social skills training", "Family psychoeducation"],
      "medications": [
        "Antipsychotics: first-generation (haloperidol, fluphenazine) and second-generation (risperidone, olanzapine, aripiprazole, clozapine for treatment-resistant cases)"
      ],
      "neuromodulation": [
        "ECT for severe catatonia or depression",
        "rTMS for negative symptoms (investigational)"
      ],
      "lifestyle_interventions": [
        "Structured daily routines",
        "Exercise and healthy diet",
        "Substance use reduction"
      ],
      "care_coordination": [
        "Assertive community treatment (ACT)",
        "Supported employment/education programs"
      ]
    },
    "treatment_goals": [
      "Reduce severity and frequency of psychotic episodes.",
      "Improve functioning and quality of life.",
      "Enhance medication adherence and insight.",
      "Prevent relapse through ongoing support."
    ],
    "missed_diagnosis_factors": [
      "Attributing early psychotic symptoms to depression, anxiety, or substance use without longitudinal assessment.",
      "Failing to recognize subtle prodromal changes."
    ],
    "overdiagnosis_factors": [
      "Misinterpreting transient stress-induced psychosis as schizophrenia.",
      "Confusing mood disorder with psychotic features for primary psychotic disorder."
    ],
    "specifiers": {
      "first_episode": "First episode of psychosis meeting full criteria.",
      "multiple_episodes": "Two or more episodes, with or without residual symptoms.",
      "continuous": "Symptoms meet criteria throughout the majority of the illness course.",
      "with_catatonia": "Catatonic symptoms present."
    },
    "warning_signs": [
      "Progressive social withdrawal and decline in functioning.",
      "Emergence of fixed false beliefs or hallucinations.",
      "Marked disorganization in speech or behavior."
    ],
    "self_help_strategies": [
      "Adherence to treatment plan.",
      "Stress reduction and sleep hygiene.",
      "Peer support or group therapy."
    ],
    "developmental_stages": {
      "adolescents": [
        "Social isolation, academic decline, odd beliefs; may have more abrupt onset."
      ],
      "adults": ["Chronic course with periods of exacerbation and remission."],
      "older_adults": [
        "Possible late-onset cases; more likely to have paranoid symptoms and less severe negative symptoms."
      ]
    },
    "real_life_examples": [
      "A 20-year-old college student begins withdrawing from friends, neglecting hygiene, and expressing beliefs that classmates are spying on them; symptoms persist over six months with functional decline."
    ],
    "when_to_seek_help": "Seek urgent evaluation for psychosis, inability to care for self, or suicidal/homicidal thoughts.",
    "prognosis_factors": {
      "positive_factors": [
        "Female gender",
        "Later age of onset",
        "Good premorbid functioning",
        "Strong family support"
      ],
      "challenging_factors": [
        "Male gender",
        "Early onset",
        "Severe negative symptoms",
        "Substance use comorbidity"
      ]
    }
  },
  "status": "active"
}
